Searchable abstracts of presentations at key conferences in endocrinology

ea0013s40 | Aspects of cardiovascular risk management in diabetes | SFEBES2007

Aldosterone induced vascular inflammatory disease: Mechanisms and implications for clinical practice

Rocha Ricardo

A growing body of preclinical and clinical evidence has demonstrated that mineralocorticoids, especially aldosterone, are intimately involved in the development of target organ injury in all major target organs of hypertensive disease, and that pharmacological inhibition of mineralocorticoids, or adrenalectomy markedly reduces myocardial injury, stroke and renal vascular disease. Animal studies demonstrated that aldosterone/salt treatment induces inflammatory remodeling of cor...

ea0041ep334 | Clinical case reports - Thyroid/Others | ECE2016

Erdheim-Chester disease and papillary thyroid carcinoma: case report of a common association in a rare disease

Aparicio David , Martins Nuno , Leichsenring Carlos , Rodrigues Alice , Joao Ana , Soares Antonio , Fragoso Marta , Marinho Rui , Rocha Ricardo , Sousa Marta , Gouminski Serguei , Sobrinho Cisaltina , Dias Wima , Afonso Enio , Geraldes Vasco , Nunes Vitor

Introdution: Erdheim-Chester disease is a rare multisystemic form of Non-langerhans cell histiocytosis CD67 positive, with approximately 550 published cases. Papillary carcinoma is the most common thyroid cancer with BRAF V600E the most common mutation. Both diseases may be associated to BRAF V600E mutation. If Erdheim- Chester disease is positive to this mutation on histiocytes, a specific pharmacolgical treatment is available, (vemurafenib), with better results.<p class=...